Isono, T., Kagiyama, N., Shibata, S., Nakajima, H., Matsui, Y., Takano, K., . . . Takayanagi, N. (2021). A retrospective analysis of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for advanced or recurrent non‐small cell lung cancer. Thorac Cancer.
Style de citation ChicagoIsono, Taisuke, et al. "A Retrospective Analysis of Pembrolizumab Plus Chemotherapy Versus Pembrolizumab Monotherapy for Advanced or Recurrent Non‐small Cell Lung Cancer." Thorac Cancer 2021.
Style de citation MLAIsono, Taisuke, et al. "A Retrospective Analysis of Pembrolizumab Plus Chemotherapy Versus Pembrolizumab Monotherapy for Advanced or Recurrent Non‐small Cell Lung Cancer." Thorac Cancer 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.